The rational management of fibromyalgia patients

被引:59
作者
Bennett, RM [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Med OP09, Portland, OR 97201 USA
关键词
D O I
10.1016/S0889-857X(02)00002-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The exponential increase in pain research over the last 10 years has established fibromyalgia (FM) as a common chronic pain syndrome with similar neurophysiologic aberrations to other chronic pain states. As such, the pathogenesis is considered to involve an interaction of augmented sensory processing (central sensitization) and peripheral pain generators. The notion, that FM symptomatology results from an amplification of incoming sensory impulses, has revolutionized the contemporary understanding of this enigmatic problem and provided a more rational approach to treatment. To date, the management of FM has been mainly palliative, with the aims of reducing pain, improving sleep, maintaining function, treating psychologic distress and diminishing the impact of associated syndromes. The rapidly evolving neurophysiologic, psychophysiologic and molecular biologic basis for chronic pain states has already opened up new avenues for management which should be applicable to this difficult group of patients. Indeed, it is now possible to think about a "rational" approach to managing FM patients that was unthinkable just a few years ago.
引用
收藏
页码:181 / +
页数:20
相关论文
共 114 条
  • [1] Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia
    Affleck, G
    Urrows, S
    Tennen, H
    Higgins, P
    Abeles, M
    [J]. PAIN, 1996, 68 (2-3) : 363 - 368
  • [2] Alertness-enhancing drugs as a countermeasure to fatigue in irregular work hours
    Akerstedt, T
    Ficca, G
    [J]. CHRONOBIOLOGY INTERNATIONAL, 1997, 14 (02) : 145 - 158
  • [3] Antidepressant treatment of fibromyalgia : A meta-analysis and review
    Arnold, LM
    Keck, PE
    Welge, JA
    [J]. PSYCHOSOMATICS, 2000, 41 (02) : 104 - 113
  • [4] The concurrence of lupus and fibromyalgia: implications for diagnosis and management
    Bennett, R
    [J]. LUPUS, 1997, 6 (06) : 494 - 499
  • [5] Bennett R, 1996, J MUSCULOSKELET PAIN, V4, P35
  • [6] A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia
    Bennett, RM
    Clark, SC
    Walczyk, J
    [J]. AMERICAN JOURNAL OF MEDICINE, 1998, 104 (03) : 227 - 231
  • [7] SYMPTOMS OF RAYNAUDS SYNDROME IN PATIENTS WITH FIBROMYALGIA - A STUDY UTILIZING THE NIELSEN TEST, DIGITAL PHOTOPLETHYSMOGRAPHY, AND MEASUREMENTS OF PLATELET ALPHA-2-ADRENERGIC RECEPTORS
    BENNETT, RM
    CLARK, SR
    CAMPBELL, SM
    INGRAM, SB
    BURKHARDT, CS
    NELSON, DL
    PORTER, JM
    [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (03): : 264 - 269
  • [8] A COMPARISON OF CYCLOBENZAPRINE AND PLACEBO IN THE MANAGEMENT OF FIBROSITIS - A DOUBLE-BLIND CONTROLLED-STUDY
    BENNETT, RM
    GATTER, RA
    CAMPBELL, SM
    ANDREWS, RP
    CLARK, SR
    SCAROLA, JA
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (12): : 1535 - 1542
  • [9] LOW-LEVELS OF SOMATOMEDIN C IN PATIENTS WITH THE FIBROMYALGIA SYNDROME - A POSSIBLE LINK BETWEEN SLEEP AND MUSCLE PAIN
    BENNETT, RM
    CLARK, SR
    CAMPBELL, SM
    BURCKHARDT, CS
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (10): : 1113 - 1116
  • [10] Bennett RM, 1997, J RHEUMATOL, V24, P1384